COST ANALYSIS OF RALTEGRAVIR VERSUS ATAZANAVIR/R OR DARUNAVIR/R FOR TREATMENT-NAIVE ADULTS WITH HIV-1 INFECTION IN THE UNITED STATES

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1207
https://www.valueinhealthjournal.com/article/S1098-3015(16)01275-4/fulltext
Title : COST ANALYSIS OF RALTEGRAVIR VERSUS ATAZANAVIR/R OR DARUNAVIR/R FOR TREATMENT-NAIVE ADULTS WITH HIV-1 INFECTION IN THE UNITED STATES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01275-4&doi=10.1016/j.jval.2016.03.1207
First page : A214
Section Title : Infection - Cost Studies
Open access? : No
Section Order : 706
Categories :
Tags :
Regions :
ViH Article Tags :